Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021
HomeAmbiusVIRUSKILLER Launches Reports Ambius: Provides Complete Indoor Air Safety

VIRUSKILLER Launches Reports Ambius: Provides Complete Indoor Air Safety

VIRUSKILLER a new range of air purification units has launched reports Ambius.

The premium technology filters, neutralizes and decontaminates indoor air to help improve air quality, prevent cross-infection, boost well-being and provide reassurance for people spending time indoors.

VIRUSKILLER is designed to protect against harmful allergens, toxic gases, airborne viruses and bacteria, providing an unrivalled performance for all-in-one indoor air safety. While many air purifiers can remove airborne pathogens, VIRUSKILLER goes a step further, drawing in contaminated air through a triple layer of filters then moving it into the patented UV-C Reactor Chamber. This process deactivates organic viruses and germs, producing pure, clean air.

“The importance of indoor air quality will be long-lasting post-pandemic,” said John Myers, President and CEO of Rentokil, parent company of Ambius. “COVID-19 has reemphasized the need to have clean, healthy air where we live, work, learn and play. The VIRUSKILLER  range of units is designed to kill your virus concerns and help make spaces safer and healthier, offering the world’s most awarded clean air technology in homes and businesses.”

VIRUSKILLER is available in several sizes to suit different environments, from a personal air purification unit to one that can cover up to 1770 square feet at 380 cubic feet per hour. Each unit offers a sleek, dynamic and free-standing design, with real-time monitoring providing VOC and dust light indicators to show the current state of the air quality. Equipped with customizable settings such as three different fan speeds, these devices can be adjusted according to current air needs.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy